Premium
F2‐02‐04: TARGETING ABERRANT CHOLESTEROL METABOLISM IN ALZHEIMER'S DISEASE: DRUG DISCOVERY IN IPSC‐DERIVED NEURONS
Author(s) -
Kant Rik
Publication year - 2019
Publication title -
alzheimer's and dementia
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2019.06.4423
Subject(s) - phenotype , tauopathy , apolipoprotein e , biology , cholesterol , lipid metabolism , neurodegeneration , phenotypic screening , drug discovery , alzheimer's disease , trem2 , disease , gene , bioinformatics , neuroscience , genetics , medicine , endocrinology , receptor , myeloid cells